Literature DB >> 23415569

Manifestations of HIV infection in the peripheral nervous system.

Chad M Centner1, Kathleen J Bateman, Jeannine M Heckmann.   

Abstract

Peripheral nerve disorders are associated with all stages of HIV infection. Distal sensory polyneuropathy is characterised by often-disabling pain that is difficult to treat. It is prevalent in both high-income and low-income settings. In low-income settings, use of potentially neurotoxic antiretrovirals, which are inexpensive and widely available, contributes substantially to incidence. Research has focused on identification of factors that predict risk of distal sensory polyneuropathy and elucidation of the multifactorial mechanisms behind pathogenesis. Sensorimotor polyneuropathies and polyradiculopathies are less frequent than distal sensory polyneuropathy, but still occur in low-income settings and have potentially devastating consequences. However, many of these diseases can be treated successfully with a combination of antiretroviral and immune-modulating therapies. To distinguish between peripheral nerve disorders that have diverse, overlapping, and frequently atypical presentations can be challenging; a framework based on a clinicoanatomical approach might assist in the diagnosis and management of such disorders.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23415569     DOI: 10.1016/S1474-4422(13)70002-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  23 in total

1.  Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.

Authors:  Michelle Kvalsund; Takondwa Chidumayo; Johanna Hamel; David Herrmann; Douglas Heimburger; Amanda Peltier; Gretchen Birbeck
Journal:  J Neurol Sci       Date:  2018-02-22       Impact factor: 3.181

Review 2.  Neuropathic pain: current definition and review of drug treatment.

Authors:  Bridin P Murnion
Journal:  Aust Prescr       Date:  2018-06-01

Review 3.  Mitotoxicity in distal symmetrical sensory peripheral neuropathies.

Authors:  Gary J Bennett; Timothy Doyle; Daniela Salvemini
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

4.  Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy.

Authors:  Dennis Kolson
Journal:  Top Antivir Med       Date:  2017 Jul/Aug

5.  Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

Authors:  Alyssa C Vecchio; Christina M Marra; Jeffrey Schouten; Hongyu Jiang; Johnstone Kumwenda; Khuanchai Supparatpinyo; James Hakim; Ned Sacktor; Thomas B Campbell; Srikanth Tripathy; Nagalingeswaran Kumarasamy; Alberto La Rosa; Breno Santos; Marcus T Silva; Cecilia Kanyama; Cindy Firnhaber; Mina C Hosseinipour; Rosie Mngqibisa; Colin Hall; Paola Cinque; Kevin Robertson
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

6.  Neurological Complications in Controlled HIV Infection.

Authors:  Kate M Crossley; Bruce J Brew
Journal:  Curr Infect Dis Rep       Date:  2013-12       Impact factor: 3.725

Review 7.  HIV Neuropathy-a Review of Mechanisms, Diagnosis, and Treatment of Pain.

Authors:  Kaitlyn E Egan; Gregory M Caldwell; Maxim S Eckmann
Journal:  Curr Pain Headache Rep       Date:  2021-07-08

8.  Sensory neuropathy and metabolic risk factors in human immune deficiency virus infected South Africans receiving protease inhibitors.

Authors:  John-Randel Vermaak; Joel A Dave; Naomi Levitt; Jeannine M Heckmann
Journal:  AIDS Res Ther       Date:  2015-09-23       Impact factor: 2.250

Review 9.  Mimics and chameleons in motor neurone disease.

Authors:  Martin R Turner; Kevin Talbot
Journal:  Pract Neurol       Date:  2013-04-24

10.  Plasma cytokine profiles in HIV-1 infected patients developing neuropathic symptoms shortly after commencing antiretroviral therapy: a case-control study.

Authors:  Johan J Van der Watt; Katalin A Wilkinson; Robert J Wilkinson; Jeannine M Heckmann
Journal:  BMC Infect Dis       Date:  2014-02-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.